-
-
Fosun Attends Forum Themed “Promoting Macao as a Platform Connecting China and Portuguese-speaking Countries” at the CIIE
2022-11-07
Fostering Economic and Trade Development Between China and Portuguese-speaking Countries (PSCs)
-
-
Fosun Participates in the CIIE for the Fifth Consecutive Year with the Debut of Innovative Products in China
2022-11-04
The 5th China International Import Expo (hereinafter referred to as the “CIIE”) will be held in Shanghai from 5 November to 10 November. Fosun will participate in the CIIE for the fifth consecutive year with its overseas member companies and partners from the global pharmaceutical and health industry, presenting a variety of China's first and industry-leading medical devices and innovative drugs to showcase Fosun's latest achievements in technology and innovation and global industrial operations and promote more "exhibits" to launch as “products” in China.
-
-
“Fosun Family” Run To Love 2022 | Together for a Better Life
2022-11-01
Time flies, and in the blink of an eye, Fosun celebrates its 30th anniversary this year. Over the past 30 years, Fosun has always adhered to the original aspiration of "Contribution to Society", encouraged employees to participate in public welfare activities, and launched a number of public welfare projects to practice corporate social responsibility. This year's "Fosun Family" Run to Love kicked off in August, leaving footprints all over the world. Let us take a look at the Run to Love event!
-
-
Fosun Pharma Announces Results for the First Three Quarters of 2022
2022-10-30
Stable Growth in Revenue and Recurring Income, Achieving a Year-on-year Increase of the Net Profit (After Extraordinary Gain or Loss) Attributable to Shareholders of the Listed Company of 15.51%, and Promoting the Internationalization Strategy Consistently(October 30, 2022, Shanghai, China) On October 30, 2022,Shanghai Fosun Pharma (Group
-
-
Groundbreaking Ceremony for Tridem Pharma's New French Headquarter and European Distribution Center to Build A Leading Intelligent Drug Distribution Platform in Europe
2022-10-27
(October 27, 2022, Belberaud, France and Shanghai, China) On October 25, 2022 (local time), the groundbreaking ceremony for the new French Headquarter and European Distribution Center of Tridem Pharma, a Fosun Pharma company (Stock code: 600196.SH; 02196.HK), was successfully held in Belberaud, a city in south France. It marks a solid s
-
-
Fosun International Garners Two Major ESG Reporting Accolades in Hong Kong
2022-10-24
(Hong Kong, 24 October 2022) Fosun International Limited (HKEX stock code: 00656) recently garnered two Environmental, Social, and Governance (ESG) reporting accolades by two major industry authoritative organizations, namely The Hong Kong Management Association (HKMA) and Hong Kong ESG Reporting Awards (HERA), reflecting the recognition of the Company'
-
-
Statement
2022-10-24
Fosun International Limited (the “Company”) officially notified Moody’s on 12 October 2022 to terminate its business engagement with Moody's rating service and ceased to provide the Company’s relevant information to Moody’s effective from that day.Fosun International Limited 24 October 2022
-
-
Club Med's recovery accelerates, net profit turns around strongly. Fosun Tourism's business volume of tourism operation for the first three quarters of 2022 surges 110%
2022-10-21
(Hong Kong, 20 October 2022) – Fosun Tourism Group (“Fosun Tourism” or the “Group”, Hong Kong Stock Exchange Stock Code: 1992), a world-leading leisure-focused integrated, tourism group, announced its operating performance1 for the nine months ended 30 September 2022 (the "first three quarters of 2022"). In the first three quarters of 2022, Club
-
-
Lanvin Group Revenue up 73% to €202 Million in First Half of 2022
2022-10-17
73% YoY revenue growth represents one of the highest growth rates in the global luxury industry; flagship brand Lanvin achieved 117% global sales growth YoY during the period, with wholesale up 260% YoY, underscoring success of an improved product and merchandising strategy, with refreshed brand appealExisting business on track to achieve positive 2022 results; growth strat